<?xml version="1.0" encoding="UTF-8"?>
<p>The study on blood sera testing was approved by the Ethics Committee IRB 00001360 affiliated with the Federal Budgetary Research Institution State Research Center of Virology and Biotechnology “Vector” (
 <ext-link ext-link-type="uri" xlink:href="http://www.vector.nsc.ru/eticheskiy-komitet/" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.vector.nsc.ru/eticheskiy-komitet/</ext-link>). Blood samples were collected from donors who provided written informed consent on condition of anonymity. Sera were collected at the Sanitary-and-Epidemiological Centers of the Federal Service for Surveillance of Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor, 
 <ext-link ext-link-type="uri" xlink:href="https://rospotrebnadzor.ru/region/structure/str_fguz.php" xmlns:xlink="http://www.w3.org/1999/xlink">https://rospotrebnadzor.ru/region/structure/str_fguz.php</ext-link>) in 37 regions of Russia with 100–200 samples collected per region. The places of collection were located close to flyways and breeding grounds of wild waterfowl. Sera collection from healthy donors, transporting the clinical material to the State Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor (SRC VB “Vector”, Rospotrebnadzor) and the hemagglutination inhibition (HI) test were performed as previously described [
 <xref rid="pone.0220401.ref006" ref-type="bibr">6</xref>].
</p>
